is semaglutide still on the shortage list As of February 21, 2025, FDA updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A US judge upholds FDA's removal
Description
GIP may also complement the appetite-suppressing effects of GLP-1 and improve fat metabolism
fat oxidation and mobilization
Consumers would be spending in other categories, though, so the household microeconomics of the GLP-1s could increase demand for new clothing, gym memberships, and perhaps even tourism if the individual feels more mobile to travel
Evidence-based comparison of exenatide (Byetta/Bydureon) and liraglutide (Victoza/Saxenda), including the LEAD-6 head-to-head trial, DURATION vs SCALE data, and the evolution from exendin-4-based to human GLP-1-based analogs.
Head-to-head SURMOUNT-5 data: Zepbound delivered 20.2% vs Wegovy's 13.7% weight loss
